Buchumschlag

Research Communication: Effects of Screening Colonoscopy on Colorectal Cancer Mortality: Lessons From Comparative Analyses of Randomised Trials

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Hermann Brenner, Dmitry Sergeev, Thomas Heisser, Michael Hoffmeister
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	Alimentary Pharmacology & Therapeutics
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Letter: Enhancing Risk‐Adapted Colorectal Cancer Screening for People With Diabetes—Authors' Reply
von: Teresa Seum, et al.
Veröffentlicht: (2025)

Editorial: ‘Risk‐Adapted Starting Ages of Colorectal Cancer Screening for People With Diabetes or Metabolic Syndrome’. Authors' Reply
von: Hermann Brenner, et al.
Veröffentlicht: (2025)

Editorial: Right‐Sizing Colonoscopy Referrals for Patients With Possible Signs and Symptoms of Colorectal Cancer
von: Nicole P. Mirabadi, et al.
Veröffentlicht: (2025)

Diagnostic Accuracy of an Add‐On, Blood‐Based Screening Test for Colorectal Cancer in Two Established Screening Programmes
von: Tim L. Kortlever, et al.
Veröffentlicht: (2025)

Research Communication: Teriflunomide Does Not Affect Gluten‐Specific T‐Cell Activity in Coeliac Disease—A Randomised, Placebo‐Controlled Trial
von: Louise F. Risnes, et al.
Veröffentlicht: (2025)

Editorial: ‘Risk‐Adapted Starting Ages of Colorectal Cancer Screening for People With Diabetes or Metabolic Syndrome’
von: James Turvill
Veröffentlicht: (2025)

Meta‐Analysis of Placebo‐Treated Patients: Dropout Rates From Treatment in MASH Randomised Controlled Trials
von: Matheus Souza, et al.
Veröffentlicht: (2025)

Clinical Trial: Semaglutide Versus Placebo in NIT ‐Assessed MASH —A Multicenter Randomised Placebo‐Controlled Trial ( SAMARA )
von: Veeral Ajmera, et al.
Veröffentlicht: (2026)

Editorial: Good Vibrations for Better Colonoscopy Preparation and Constipation
von: Benjamin Kalivas, et al.
Veröffentlicht: (2025)

Clinical Trial: Long Versus Short Tapering of Steroids in Steroid Responsive Moderate to Severely Active Ulcerative Colitis—A Randomised Controlled Trial
von: Ankit Kumar, et al.
Veröffentlicht: (2026)

Lubiprostone Reduces Fat Content on MRI‐PDFF in Patients With MASLD: A 48‐Week Randomised Controlled Trial
von: Mohamed El‐Kassas, et al.
Veröffentlicht: (2025)

Letter on ‘Clinical Trial: Effect of a 28‐Day Low FODMAP Diet on Gastrointestinal Symptoms Associated With Endometriosis ( EndoFOD )—A Randomised, Controlled Crossover Feeding Study’
von: Wancheng Zhao, et al.
Veröffentlicht: (2025)

Letter: FIT ‐Based Triage for Symptomatic Colonoscopy‐Diagnostic Yield Is Not the Same as Pathway Safety
von: Stjepan Škudar
Veröffentlicht: (2026)

Letter: Incidence and Predictors of Major Gastrointestinal Bleeding in Patients on Aspirin, Low‐Dose Rivaroxaban or the Combination: Secondary Analysis of the COMPASS Randomised Controlled Trial
von: Yu Yang, et al.
Veröffentlicht: (2024)

Letter: Balancing Cost and Consequence of Colon Capsule Endoscopy in Colorectal Cancer Pathways—Finding the Sweet Spot
von: Ian Io Lei, et al.
Veröffentlicht: (2025)

Letter: Methodological Gaps Undermine Conclusions on Electronic Nose Use for Colorectal Cancer Detection—Authors' Reply
von: Milou. L. M. van Riswijk, et al.
Veröffentlicht: (2025)

Real‐World Performance of FIT Triage for Symptomatic Colonoscopy: Analysis of the UK National Endoscopy Database ( NED )
von: David Beaton, et al.
Veröffentlicht: (2026)

Letter: Incidence and Predictors of Major Gastrointestinal Bleeding in Patients on Aspirin, Low‐Dose Rivaroxaban or the Combination: Secondary Analysis of the COMPASS Randomised Controlled Trial. Authors' Reply
von: Nauzer Forbes, et al.
Veröffentlicht: (2024)

Editorial: Surveillance Colonoscopy for Detection of Neoplasia in Inflammatory Bowel Disease—Is Dye‐Based Chromoendoscopy Always the Final Answer?
von: Andrea Cassinotti, et al.
Veröffentlicht: (2025)

Research Communication: An Observational Cohort Study on Risk of Ovarian Cancer in Women with Irritable Bowel Syndrome
von: Andrea Shin, et al.
Veröffentlicht: (2025)

Editorial: Toward Safer Pain Management in IBD—Lessons From Prescription Patterns
von: Shabari Shenoy, et al.
Veröffentlicht: (2025)

Editorial: High‐Grade Dysplasia in Colonic Inflammatory Bowel Disease Is Associated With a High Risk of Synchronous or Metachronous Colorectal Cancer
von: Alexandra Hickey, et al.
Veröffentlicht: (2025)

Chronic Use of Proton Pump Inhibitors Is Associated With Reduced 30‐Day Mortality From Acute Pancreatitis
von: Maya Fischman, et al.
Veröffentlicht: (2025)

Primary Sclerosing Cholangitis in the Absence of Inflammatory Bowel Disease Increases the Risk of Colorectal Cancer: A Multi‐Centre Propensity Score Matched Analysis
von: Saqr Alsakarneh, et al.
Veröffentlicht: (2025)

Editorial: High‐Grade Dysplasia in Colonic Inflammatory Bowel Disease Is Associated With a High Risk of Synchronous or Metachronous Colorectal Cancer—Authors' Reply
von: Monica E. W. Derks, et al.
Veröffentlicht: (2025)

Editorial: Toward Safer Pain Management in IBD—Lessons From Prescription Patterns. Authors' Reply
von: Samantha Baillie, et al.
Veröffentlicht: (2025)

Clinical Trial: Treatment of Functional Dyspepsia According to Subtype Compared With Empirical Proton Pump Inhibitor
von: Kee Huat Chuah, et al.
Veröffentlicht: (2024)

Efficacy and Safety of Vedolizumab and Tofacitinib ( VETO ) Combination Therapy in Refractory Ulcerative Colitis Unresponsive to Anti‐ TNF and a Second‐Line Advanced Therapy: A Prospective Cohort Nested Within a Randomised Trial
von: Pardhu Bharath Neelam, et al.
Veröffentlicht: (2025)

Letter: Clinical Trial: Treatment of Functional Dyspepsia According to Subtype Compared With Empirical Proton Pump Inhibitor
von: Shoko Miyahara, et al.
Veröffentlicht: (2025)

Editorial: Understanding How Social Determinants of Health Impact Mortality in MASLD —Insights From a National Analysis. Authors' Reply
von: Donghee Kim, et al.
Veröffentlicht: (2025)

Successful Amendment of an Existing Hepatitis B Screening Programme by a Guideline Recommended Hepatitis D Screening in the Primary Care Setting
von: Toni Herta, et al.
Veröffentlicht: (2024)

Editorial: Carvedilol Remains the First‐Line Treatment of Portal Hypertension After the CALIBRE Trial
von: Thomas Reiberger, et al.
Veröffentlicht: (2025)

Letter: Clinical Trial: Treatment of Functional Dyspepsia According to Subtype Compared With Empirical Proton Pump Inhibitor: Authors' Reply
von: Kee Huat Chuah, et al.
Veröffentlicht: (2025)

Research Communication: The Cumulated Spontaneous Portosystemic Shunts ( SPSS ) Area Decreases After TIPS and Impacts on Prognosis
von: Marlene Hintersteininger, et al.
Veröffentlicht: (2025)

Alcohol‐Attributable Cancer: Update From the Global Burden of Disease 2021 Study
von: Pojsakorn Danpanichkul, et al.
Veröffentlicht: (2025)

Editorial: Hepatitis D Screening—DAS (Delta Virus Awareness and Screening) Approach in Primary Care
von: Noreen Singh, et al.
Veröffentlicht: (2025)

Systematic Review: The Relationship Between the Faecal Microbiome and Colorectal Neoplasia in Shotgun Metagenomic Studies
von: Sarah Manning, et al.
Veröffentlicht: (2025)

Amino Acid Imbalance Is an Independent Factor for Mortality in Patients With Liver Cirrhosis
von: Yuki Utakata, et al.
Veröffentlicht: (2026)

Editorial: Mortality in immune‐mediated inflammatory diseases during early adulthood
von: Paul Henderson
Veröffentlicht: (2024)

Meta‐Analysis: Mortality Trends and Risk Factors in Severe Alcohol‐Associated Hepatitis
von: Mushfiqur R. Siddique, et al.
Veröffentlicht: (2025)